BioXcel Therapeutics Inc.
BTAI
|
|
| |
|
| Trading Volume | 11,914 |
|
|
5.51 - 0.60 |
| Market Cap Full | $ 18.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 7.2% | -4.2% | -13.1% | 2.9% |
| Q2 | - | -55.5% | -64.3% | -36.9% |
| Q3 | - | -43.3% | -62% | -10.5% |
| Q4 | - | -20.3% | 21.4% | 81.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 9.2 | -1.2 | -11.2 | 0.5 | -38.4 | -28 | -11.1 | -43.3 | - | - | - | - |
| 2023 | |||||||||||
| 32.8 | 11.9 | -41.5 | 10.5 | -13 | -62.9 | 37.2 | -58.6 | -33.1 | 58.7 | -5.4 | -22.4 |
| 2022 | |||||||||||
| -16.9 | 9.4 | 13.1 | -33.5 | -13.8 | 10.1 | 15.6 | -10.4 | -13.6 | 6.5 | 31.6 | 29.6 |
| 2021 | |||||||||||
| 0.3 | 15.7 | -20.9 | -19.9 | -2.8 | -12 | -11.9 | 15.1 | 3.1 | -2.7 | -23 | -10.6 |
| 2020 | |||||||||||
| 43.8 | 114.5 | -35.9 | 65.6 | 25.8 | 13.9 | -14.4 | -10.2 | 6.4 | 5.4 | -3.7 | 5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.8 | -1.1 | -1.1 | -0.8 |
| Q2 | -1.8 | -1.4 | -1.1 | -1.1 |
| Q3 | -1.7 | -1.5 | -1 | -1.1 |
| Q4 | 0 | -2 | -0.9 | -0.9 |
| A | -5.39 | -5.9 | -4.1 | -3.8 |